QuidelOrtho
QDEL
$85.74
Share price
0.81%
Change (1 day)
-8.19%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total assets
Total assets on the balance sheet as of March 2023 : $8.78 B
According to QuidelOrtho's latest financial reports the company's total assets are $8.78 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
QuidelOrtho - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $8.85 B | 264.38% |
| 2021-12-31 | $2.43 B | 29.89% |
| 2020-12-31 | $1.87 B | 105.43% |
| 2019-12-31 | $0.91 B | 12.96% |
| 2018-12-31 | $0.80 B | -13.78% |
| 2017-12-31 | $0.93 B | 140.89% |
| 2016-12-31 | $0.38 B | -4.49% |
| 2015-12-31 | $0.40 B | -9.98% |
| 2014-12-31 | $0.45 B | 66.33% |
| 2013-12-31 | $0.27 B | 12.14% |
| 2012-12-31 | $0.24 B | -13.19% |
| 2011-12-31 | $0.27 B | 29.96% |
| 2010-12-31 | $0.21 B | 29% |
| 2009-12-31 | $0.16 B | 16.48% |
| 2008-12-31 | $0.14 B | 6.7% |
| 2007-12-31 | $0.13 B | 5.34% |
| 2006-12-31 | $0.12 B | 11.59% |
| 2005-12-31 | $0.11 B | 1.03% |
| 2004-12-31 | $0.11 B | -4.03% |
| 2003-12-31 | $0.11 B | 42.17% |
| 2002-12-31 | $82.59 M | 0.24% |
| 2001-12-31 | $82.39 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $94.65 B | 977.24% | 🇺🇸 USA |
 Becton Dickinson BDX | $54.39 B | 519.02% | 🇺🇸 USA |
 Danaher DHR | $85.04 B | 867.78% | 🇺🇸 USA |
 PerkinElmer
PKI | $14.12 B | 60.80% | 🇺🇸 USA |
 OraSure Technologies OSUR | $0.44 B | -94.94% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.46 B | -94.73% | 🇺🇸 USA |